Asset Lifecycle The March 2025 asset sale to Ostial suggests valuable CVI technology assets may be available for licensing or collaboration, creating opportunities for BD outreach.

Lean Ops With a small team, Crossfire is likely open to external manufacturing, regulatory, distribution, and development partnerships to accelerate market entry for CVI catheter technologies.

CVI Focus The emphasis on peripheral vascular catheter manufacturing for CVI and existing physician relationships create an opening for hospital systems and vascular clinics to explore collaborations or licensing of next generation devices.

Midwest Access Based in Minneapolis, Crossfire can be a convenient regional partner for U.S. healthcare networks and academic centers, enabling faster pilot deployments and regional distribution opportunities in the Midwest.

Digital Growth The existing tech stack signals readiness for digital marketing and data driven lead generation; offer sales enablement, CRM optimization, and analytics driven campaigns to attract physician customers and accelerate engagement.